PharmaShots | Incisive News in 3 Shots

Subscribe Now

breakthrough designation

PharmaShots Interview: BoneHealth Technologies' Laura Yecies Shares Insights on OsteoBoost Vibration Belt

PharmaShots Interview: BoneHealth Technologies' Laura Yecies Shares Insights on OsteoBoost Vibration Belt

February 2, 2021

Novartis' Ligelizumab (QGE031) Receives the US FDA's Breakthrough Designation for Patients with Chronic Spontaneous Urticaria

Novartis' Ligelizumab (QGE031) Receives the US FDA's Breakthrough Designation for Patients with Chronic Spontaneous Urticaria

January 15, 2021

Inventiva's Lanifibranor Receives the US FDA's Breakthrough Designation for the Treatment of NASH

Inventiva's Lanifibranor Receives the US FDA's Breakthrough Designation for the Treatment of NASH

October 12, 2020

PharmaShots' Key Highlights of First Quarter 2019

PharmaShots' Key Highlights of First Quarter 2019

August 4, 2019

Nektar and BMS Receive the US FDA's Breakthrough Designation for Bempegaldesleukin (NKTR-214) + Opdivo (nivolumab) to Treat Advanced Melanoma

Nektar and BMS Receive the US FDA's Breakthrough Designation for Bempegaldesleukin (NKTR-214) + Opdivo (nivolumab) to Treat Advanc...

August 2, 2019

Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable Hepatocellular Carcinoma

Merck and Eisai's Dual Regimen Receives the US FDA's Breakthrough Therapy Designation as 1L Treatment for Advanced Unresectable He...

July 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us